Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Breath Acetone Correlates With Capillary β-hydroxybutyrate in Type 1 Diabetes.
Journal: Journal of diabetes science and technology
Published: April 22, 2025
Breath Acetone Correlates with Capillary β-hydroxybutyrate in Type 1 Diabetes.
Journal: medRxiv : the preprint server for health sciences
Published: February 20, 2025
Effect of dapagliflozin on blood and breath ketones during supervised insulin withdrawal in adults with type 1 diabetes: A randomized crossover trial.
Journal: Diabetes, obesity & metabolism
Published: December 13, 2024
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
Journal: Diabetes care
Published: July 20, 2023
MODY5 and Serous Ovarian Carcinoma in 17q12 Recurrent Deletion Syndrome.
Journal: AACE clinical case reports
Published: February 02, 2023
Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study.
Journal: Cancer & metabolism
Published: January 17, 2023
A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes.
Journal: Diabetes technology & therapeutics
Published: December 06, 2022
A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes.
Journal: Diabetes technology & therapeutics
Published: September 29, 2022
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
Journal: The New England journal of medicine
Published: September 28, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
Journal: Diabetes technology & therapeutics
Published: March 16, 2022
Insulin Receptor Autoantibody-mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease.
Insulin Receptor Autoantibody-mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease.
Journal: Journal of the Endocrine Society
Published: October 08, 2021
Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study.
Journal: Journal of diabetes science and technology
Published: December 24, 2019
Last Updated: 09/26/2026